うつ病治療世界市場の発展状況と動向 2024-2030
英文タイトル: Global Depression Treatment Therapy Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書はうつ病治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはうつ病治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。
世界のうつ病治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはうつ病治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にうつ病治療市場を分類しています。本研究に含まれる主な企業は:Pfizer、Teva Pharmaceutical、Johnson and Johnson、Merck、Eli Lily、Novartis、Sanofi、AstraZeneca、Allergan、Mayo Clinic、Bristol-Myers Squibb、Takeda、Brainsway、Lundbeck、NeuroStar、Otsuka、VistaGen Therapeutics、Silver Oak Health、NeuroSigma
地域別市場区分、地域別分析は以下の通り:
アメリカとカナダ
中国
アジア
ヨーロッパ
中東、アフリカ、ラテンアメリカ
タイプ別市場セグメント:
Drugs
Treatment device
用途別の市場セグメント:
Seasonal affective disorder (SAD)
Major depression
Dysthymia disorder
Postpartum depression
Atypical depression
Psychotic depression
Other
本レポートの詳細内容
世界のうつ病治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、うつ病治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のうつ病治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のうつ病治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、うつ病治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
うつ病治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章の概要
第1章:うつ病治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(2019~2030)
第2章:うつ病治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(2019~2030)
第3章うつ病治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(2019~2030)
第4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2024)
第5章:うつ病治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第8章:中国の種類別、および用途別、各セグメントの収益。(2019~2030)
第9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(2019~2030)
第10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第11章:うつ病治療の主要企業の概要を提供し、製品の説明と仕様、うつ病治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(2019~2024)
第12章:アナリストの見解/結論
概要
Market Analysis and Insights: Global Depression Treatment Therapy Market The global Depression Treatment Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Depression Treatment Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The China market for Depression Treatment Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The Europe market for Depression Treatment Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030. The global key companies of Depression Treatment Therapy include Pfizer, Teva Pharmaceutical, Johnson and Johnson, Merck, Eli Lily, Novartis, Sanofi, AstraZeneca and Allergan, etc. In 2023, the global top five players had a share approximately % in terms of revenue. Depression Treatment Therapy is widely used in various fields, such as Seasonal affective disorder (SAD), Major depression, Dysthymia disorder and Postpartum depression, etc. Seasonal affective disorder (SAD) provides greatest supports to the Depression Treatment Therapy industry development. In 2023, global % revenue of Depression Treatment Therapy went into Seasonal affective disorder (SAD) filed and the proportion will reach to % in 2030. Report Covers: This report presents an overview of global market for Depression Treatment Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Depression Treatment Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Depression Treatment Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Depression Treatment Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Depression Treatment Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Depression Treatment Therapy revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including Pfizer, Teva Pharmaceutical, Johnson and Johnson, Merck, Eli Lily, Novartis, Sanofi, AstraZeneca and Allergan, etc. Market Segmentation By Company Pfizer Teva Pharmaceutical Johnson and Johnson Merck Eli Lily Novartis Sanofi AstraZeneca Allergan Mayo Clinic Bristol-Myers Squibb Takeda Brainsway Lundbeck NeuroStar Otsuka VistaGen Therapeutics Silver Oak Health NeuroSigma Segment by Type Drugs Treatment device Segment by Application Seasonal affective disorder (SAD) Major depression Dysthymia disorder Postpartum depression Atypical depression Psychotic depression Other By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Depression Treatment Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Depression Treatment Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Depression Treatment Therapy revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Depression Treatment Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Drugs
1.2.3 Treatment device
1.3 Market by Application
1.3.1 Global Depression Treatment Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Seasonal affective disorder (SAD)
1.3.3 Major depression
1.3.4 Dysthymia disorder
1.3.5 Postpartum depression
1.3.6 Atypical depression
1.3.7 Psychotic depression
1.3.8 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Depression Treatment Therapy Market Perspective (2019-2030)
2.2 Global Depression Treatment Therapy Growth Trends by Region
2.2.1 Depression Treatment Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Depression Treatment Therapy Historic Market Size by Region (2019-2024)
2.2.3 Depression Treatment Therapy Forecasted Market Size by Region (2025-2030)
2.3 Depression Treatment Therapy Market Dynamics
2.3.1 Depression Treatment Therapy Industry Trends
2.3.2 Depression Treatment Therapy Market Drivers
2.3.3 Depression Treatment Therapy Market Challenges
2.3.4 Depression Treatment Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Depression Treatment Therapy by Players
3.1.1 Global Depression Treatment Therapy Revenue by Players (2019-2024)
3.1.2 Global Depression Treatment Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Depression Treatment Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Depression Treatment Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Depression Treatment Therapy Market Concentration Ratio
3.4.1 Global Depression Treatment Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Depression Treatment Therapy Revenue in 2023
3.5 Global Key Players of Depression Treatment Therapy Head office and Area Served
3.6 Global Key Players of Depression Treatment Therapy, Product and Application
3.7 Global Key Players of Depression Treatment Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Depression Treatment Therapy Breakdown Data by Type
4.1 Global Depression Treatment Therapy Historic Market Size by Type (2019-2024)
4.2 Global Depression Treatment Therapy Forecasted Market Size by Type (2025-2030)
5 Depression Treatment Therapy Breakdown Data by Application
5.1 Global Depression Treatment Therapy Historic Market Size by Application (2019-2024)
5.2 Global Depression Treatment Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Depression Treatment Therapy Market Size (2019-2030)
6.2 North America Depression Treatment Therapy Market Size by Type
6.2.1 North America Depression Treatment Therapy Market Size by Type (2019-2024)
6.2.2 North America Depression Treatment Therapy Market Size by Type (2025-2030)
6.2.3 North America Depression Treatment Therapy Market Share by Type (2019-2030)
6.3 North America Depression Treatment Therapy Market Size by Application
6.3.1 North America Depression Treatment Therapy Market Size by Application (2019-2024)
6.3.2 North America Depression Treatment Therapy Market Size by Application (2025-2030)
6.3.3 North America Depression Treatment Therapy Market Share by Application (2019-2030)
6.4 North America Depression Treatment Therapy Market Size by Country
6.4.1 North America Depression Treatment Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Depression Treatment Therapy Market Size by Country (2019-2024)
6.4.3 North America Depression Treatment Therapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Depression Treatment Therapy Market Size (2019-2030)
7.2 Europe Depression Treatment Therapy Market Size by Type
7.2.1 Europe Depression Treatment Therapy Market Size by Type (2019-2024)
7.2.2 Europe Depression Treatment Therapy Market Size by Type (2025-2030)
7.2.3 Europe Depression Treatment Therapy Market Share by Type (2019-2030)
7.3 Europe Depression Treatment Therapy Market Size by Application
7.3.1 Europe Depression Treatment Therapy Market Size by Application (2019-2024)
7.3.2 Europe Depression Treatment Therapy Market Size by Application (2025-2030)
7.3.3 Europe Depression Treatment Therapy Market Share by Application (2019-2030)
7.4 Europe Depression Treatment Therapy Market Size by Country
7.4.1 Europe Depression Treatment Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Depression Treatment Therapy Market Size by Country (2019-2024)
7.4.3 Europe Depression Treatment Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Depression Treatment Therapy Market Size (2019-2030)
8.2 China Depression Treatment Therapy Market Size by Type
8.2.1 China Depression Treatment Therapy Market Size by Type (2019-2024)
8.2.2 China Depression Treatment Therapy Market Size by Type (2025-2030)
8.2.3 China Depression Treatment Therapy Market Share by Type (2019-2030)
8.3 China Depression Treatment Therapy Market Size by Application
8.3.1 China Depression Treatment Therapy Market Size by Application (2019-2024)
8.3.2 China Depression Treatment Therapy Market Size by Application (2025-2030)
8.3.3 China Depression Treatment Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Depression Treatment Therapy Market Size (2019-2030)
9.2 Asia Depression Treatment Therapy Market Size by Type
9.2.1 Asia Depression Treatment Therapy Market Size by Type (2019-2024)
9.2.2 Asia Depression Treatment Therapy Market Size by Type (2025-2030)
9.2.3 Asia Depression Treatment Therapy Market Share by Type (2019-2030)
9.3 Asia Depression Treatment Therapy Market Size by Application
9.3.1 Asia Depression Treatment Therapy Market Size by Application (2019-2024)
9.3.2 Asia Depression Treatment Therapy Market Size by Application (2025-2030)
9.3.3 Asia Depression Treatment Therapy Market Share by Application (2019-2030)
9.4 Asia Depression Treatment Therapy Market Size by Region
9.4.1 Asia Depression Treatment Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Depression Treatment Therapy Market Size by Region (2019-2024)
9.4.3 Asia Depression Treatment Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Depression Treatment Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Depression Treatment Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Depression Treatment Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Depression Treatment Therapy Introduction
11.1.4 Pfizer Revenue in Depression Treatment Therapy Business (2019-2024)
11.1.5 Pfizer Recent Developments
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Details
11.2.2 Teva Pharmaceutical Business Overview
11.2.3 Teva Pharmaceutical Depression Treatment Therapy Introduction
11.2.4 Teva Pharmaceutical Revenue in Depression Treatment Therapy Business (2019-2024)
11.2.5 Teva Pharmaceutical Recent Developments
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Details
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Depression Treatment Therapy Introduction
11.3.4 Johnson and Johnson Revenue in Depression Treatment Therapy Business (2019-2024)
11.3.5 Johnson and Johnson Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Depression Treatment Therapy Introduction
11.4.4 Merck Revenue in Depression Treatment Therapy Business (2019-2024)
11.4.5 Merck Recent Developments
11.5 Eli Lily
11.5.1 Eli Lily Company Details
11.5.2 Eli Lily Business Overview
11.5.3 Eli Lily Depression Treatment Therapy Introduction
11.5.4 Eli Lily Revenue in Depression Treatment Therapy Business (2019-2024)
11.5.5 Eli Lily Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Depression Treatment Therapy Introduction
11.6.4 Novartis Revenue in Depression Treatment Therapy Business (2019-2024)
11.6.5 Novartis Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Depression Treatment Therapy Introduction
11.7.4 Sanofi Revenue in Depression Treatment Therapy Business (2019-2024)
11.7.5 Sanofi Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Depression Treatment Therapy Introduction
11.8.4 AstraZeneca Revenue in Depression Treatment Therapy Business (2019-2024)
11.8.5 AstraZeneca Recent Developments
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Allergan Business Overview
11.9.3 Allergan Depression Treatment Therapy Introduction
11.9.4 Allergan Revenue in Depression Treatment Therapy Business (2019-2024)
11.9.5 Allergan Recent Developments
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Details
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic Depression Treatment Therapy Introduction
11.10.4 Mayo Clinic Revenue in Depression Treatment Therapy Business (2019-2024)
11.10.5 Mayo Clinic Recent Developments
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Depression Treatment Therapy Introduction
11.11.4 Bristol-Myers Squibb Revenue in Depression Treatment Therapy Business (2019-2024)
11.11.5 Bristol-Myers Squibb Recent Developments
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Depression Treatment Therapy Introduction
11.12.4 Takeda Revenue in Depression Treatment Therapy Business (2019-2024)
11.12.5 Takeda Recent Developments
11.13 Brainsway
11.13.1 Brainsway Company Details
11.13.2 Brainsway Business Overview
11.13.3 Brainsway Depression Treatment Therapy Introduction
11.13.4 Brainsway Revenue in Depression Treatment Therapy Business (2019-2024)
11.13.5 Brainsway Recent Developments
11.14 Lundbeck
11.14.1 Lundbeck Company Details
11.14.2 Lundbeck Business Overview
11.14.3 Lundbeck Depression Treatment Therapy Introduction
11.14.4 Lundbeck Revenue in Depression Treatment Therapy Business (2019-2024)
11.14.5 Lundbeck Recent Developments
11.15 NeuroStar
11.15.1 NeuroStar Company Details
11.15.2 NeuroStar Business Overview
11.15.3 NeuroStar Depression Treatment Therapy Introduction
11.15.4 NeuroStar Revenue in Depression Treatment Therapy Business (2019-2024)
11.15.5 NeuroStar Recent Developments
11.16 Otsuka
11.16.1 Otsuka Company Details
11.16.2 Otsuka Business Overview
11.16.3 Otsuka Depression Treatment Therapy Introduction
11.16.4 Otsuka Revenue in Depression Treatment Therapy Business (2019-2024)
11.16.5 Otsuka Recent Developments
11.17 VistaGen Therapeutics
11.17.1 VistaGen Therapeutics Company Details
11.17.2 VistaGen Therapeutics Business Overview
11.17.3 VistaGen Therapeutics Depression Treatment Therapy Introduction
11.17.4 VistaGen Therapeutics Revenue in Depression Treatment Therapy Business (2019-2024)
11.17.5 VistaGen Therapeutics Recent Developments
11.18 Silver Oak Health
11.18.1 Silver Oak Health Company Details
11.18.2 Silver Oak Health Business Overview
11.18.3 Silver Oak Health Depression Treatment Therapy Introduction
11.18.4 Silver Oak Health Revenue in Depression Treatment Therapy Business (2019-2024)
11.18.5 Silver Oak Health Recent Developments
11.19 NeuroSigma
11.19.1 NeuroSigma Company Details
11.19.2 NeuroSigma Business Overview
11.19.3 NeuroSigma Depression Treatment Therapy Introduction
11.19.4 NeuroSigma Revenue in Depression Treatment Therapy Business (2019-2024)
11.19.5 NeuroSigma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Depression Treatment Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of Drugs Table 3. Key Players of Treatment device Table 4. Global Depression Treatment Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 5. Global Depression Treatment Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Depression Treatment Therapy Market Size by Region (2019-2024) & (US$ Million) Table 7. Global Depression Treatment Therapy Market Share by Region (2019-2024) Table 8. Global Depression Treatment Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 9. Global Depression Treatment Therapy Market Share by Region (2025-2030) Table 10. Depression Treatment Therapy Market Trends Table 11. Depression Treatment Therapy Market Drivers Table 12. Depression Treatment Therapy Market Challenges Table 13. Depression Treatment Therapy Market Restraints Table 14. Global Depression Treatment Therapy Revenue by Players (2019-2024) & (US$ Million) Table 15. Global Depression Treatment Therapy Revenue Share by Players (2019-2024) Table 16. Global Top Depression Treatment Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Treatment Therapy as of 2023) Table 17. Global Depression Treatment Therapy Industry Ranking 2022 VS 2023 VS 2024 Table 18. Global 5 Largest Players Market Share by Depression Treatment Therapy Revenue (CR5 and HHI) & (2019-2024) Table 19. Global Key Players of Depression Treatment Therapy, Headquarters and Area Served Table 20. Global Key Players of Depression Treatment Therapy, Product and Application Table 21. Global Key Players of Depression Treatment Therapy, Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Depression Treatment Therapy Market Size by Type (2019-2024) & (US$ Million) Table 24. Global Depression Treatment Therapy Revenue Market Share by Type (2019-2024) Table 25. Global Depression Treatment Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 26. Global Depression Treatment Therapy Revenue Market Share by Type (2025-2030) Table 27. Global Depression Treatment Therapy Market Size by Application (2019-2024) & (US$ Million) Table 28. Global Depression Treatment Therapy Revenue Share by Application (2019-2024) Table 29. Global Depression Treatment Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 30. Global Depression Treatment Therapy Revenue Share by Application (2025-2030) Table 31. North America Depression Treatment Therapy Market Size by Type (2019-2024) & (US$ Million) Table 32. North America Depression Treatment Therapy Market Size by Type (2025-2030) & (US$ Million) Table 33. North America Depression Treatment Therapy Market Size by Application (2019-2024) & (US$ Million) Table 34. North America Depression Treatment Therapy Market Size by Application (2025-2030) & (US$ Million) Table 35. North America Depression Treatment Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. North America Depression Treatment Therapy Market Size by Country (2019-2024) & (US$ Million) Table 37. North America Depression Treatment Therapy Market Size by Country (2025-2030) & (US$ Million) Table 38. Europe Depression Treatment Therapy Market Size by Type (2019-2024) & (US$ Million) Table 39. Europe Depression Treatment Therapy Market Size by Type (2025-2030) & (US$ Million) Table 40. Europe Depression Treatment Therapy Market Size by Application (2019-2024) & (US$ Million) Table 41. Europe Depression Treatment Therapy Market Size by Application (2025-2030) & (US$ Million) Table 42. Europe Depression Treatment Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 43. Europe Depression Treatment Therapy Market Size by Country (2019-2024) & (US$ Million) Table 44. Europe Depression Treatment Therapy Market Size by Country (2025-2030) & (US$ Million) Table 45. China Depression Treatment Therapy Market Size by Type (2019-2024) & (US$ Million) Table 46. China Depression Treatment Therapy Market Size by Type (2025-2030) & (US$ Million) Table 47. China Depression Treatment Therapy Market Size by Application (2019-2024) & (US$ Million) Table 48. China Depression Treatment Therapy Market Size by Application (2025-2030) & (US$ Million) Table 49. Asia Depression Treatment Therapy Market Size by Type (2019-2024) & (US$ Million) Table 50. Asia Depression Treatment Therapy Market Size by Type (2025-2030) & (US$ Million) Table 51. Asia Depression Treatment Therapy Market Size by Application (2019-2024) & (US$ Million) Table 52. Asia Depression Treatment Therapy Market Size by Application (2025-2030) & (US$ Million) Table 53. Asia Depression Treatment Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 54. Asia Depression Treatment Therapy Market Size by Region (2019-2024) & (US$ Million) Table 55. Asia Depression Treatment Therapy Market Size by Region (2025-2030) & (US$ Million) Table 56. Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Type (2019-2024) & (US$ Million) Table 57. Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Type (2025-2030) & (US$ Million) Table 58. Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Application (2019-2024) & (US$ Million) Table 59. Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Application (2025-2030) & (US$ Million) Table 60. Middle East, Africa, and Latin America Depression Treatment Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 61. Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Country (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America Depression Treatment Therapy Market Size by Country (2025-2030) & (US$ Million) Table 63. Pfizer Company Details Table 64. Pfizer Business Overview Table 65. Pfizer Depression Treatment Therapy Product Table 66. Pfizer Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 67. Pfizer Recent Developments Table 68. Teva Pharmaceutical Company Details Table 69. Teva Pharmaceutical Business Overview Table 70. Teva Pharmaceutical Depression Treatment Therapy Product Table 71. Teva Pharmaceutical Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 72. Teva Pharmaceutical Recent Developments Table 73. Johnson and Johnson Company Details Table 74. Johnson and Johnson Business Overview Table 75. Johnson and Johnson Depression Treatment Therapy Product Table 76. Johnson and Johnson Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 77. Johnson and Johnson Recent Developments Table 78. Merck Company Details Table 79. Merck Business Overview Table 80. Merck Depression Treatment Therapy Product Table 81. Merck Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 82. Merck Recent Developments Table 83. Eli Lily Company Details Table 84. Eli Lily Business Overview Table 85. Eli Lily Depression Treatment Therapy Product Table 86. Eli Lily Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 87. Eli Lily Recent Developments Table 88. Novartis Company Details Table 89. Novartis Business Overview Table 90. Novartis Depression Treatment Therapy Product Table 91. Novartis Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 92. Novartis Recent Developments Table 93. Sanofi Company Details Table 94. Sanofi Business Overview Table 95. Sanofi Depression Treatment Therapy Product Table 96. Sanofi Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 97. Sanofi Recent Developments Table 98. AstraZeneca Company Details Table 99. AstraZeneca Business Overview Table 100. AstraZeneca Depression Treatment Therapy Product Table 101. AstraZeneca Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 102. AstraZeneca Recent Developments Table 103. Allergan Company Details Table 104. Allergan Business Overview Table 105. Allergan Depression Treatment Therapy Product Table 106. Allergan Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 107. Allergan Recent Developments Table 108. Mayo Clinic Company Details Table 109. Mayo Clinic Business Overview Table 110. Mayo Clinic Depression Treatment Therapy Product Table 111. Mayo Clinic Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 112. Mayo Clinic Recent Developments Table 113. Bristol-Myers Squibb Company Details Table 114. Bristol-Myers Squibb Business Overview Table 115. Bristol-Myers Squibb Depression Treatment Therapy Product Table 116. Bristol-Myers Squibb Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 117. Bristol-Myers Squibb Recent Developments Table 118. Takeda Company Details Table 119. Takeda Business Overview Table 120. Takeda Depression Treatment Therapy Product Table 121. Takeda Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 122. Takeda Recent Developments Table 123. Brainsway Company Details Table 124. Brainsway Business Overview Table 125. Brainsway Depression Treatment Therapy Product Table 126. Brainsway Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 127. Brainsway Recent Developments Table 128. Lundbeck Company Details Table 129. Lundbeck Business Overview Table 130. Lundbeck Depression Treatment Therapy Product Table 131. Lundbeck Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 132. Lundbeck Recent Developments Table 133. NeuroStar Company Details Table 134. NeuroStar Business Overview Table 135. NeuroStar Depression Treatment Therapy Product Table 136. NeuroStar Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 137. NeuroStar Recent Developments Table 138. Otsuka Company Details Table 139. Otsuka Business Overview Table 140. Otsuka Depression Treatment Therapy Product Table 141. Otsuka Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 142. Otsuka Recent Developments Table 143. VistaGen Therapeutics Company Details Table 144. VistaGen Therapeutics Business Overview Table 145. VistaGen Therapeutics Depression Treatment Therapy Product Table 146. VistaGen Therapeutics Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 147. VistaGen Therapeutics Recent Developments Table 148. Silver Oak Health Company Details Table 149. Silver Oak Health Business Overview Table 150. Silver Oak Health Depression Treatment Therapy Product Table 151. Silver Oak Health Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 152. Silver Oak Health Recent Developments Table 153. NeuroSigma Company Details Table 154. NeuroSigma Business Overview Table 155. NeuroSigma Depression Treatment Therapy Product Table 156. NeuroSigma Revenue in Depression Treatment Therapy Business (2019-2024) & (US$ Million) Table 157. NeuroSigma Recent Developments Table 158. Research Programs/Design for This Report Table 159. Key Data Information from Secondary Sources Table 160. Key Data Information from Primary Sources List of Figures Figure 1. Global Depression Treatment Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Depression Treatment Therapy Market Share by Type: 2023 VS 2030 Figure 3. Drugs Features Figure 4. Treatment device Features Figure 5. Global Depression Treatment Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 6. Global Depression Treatment Therapy Market Share by Application: 2023 VS 2030 Figure 7. Seasonal affective disorder (SAD) Case Studies Figure 8. Major depression Case Studies Figure 9. Dysthymia disorder Case Studies Figure 10. Postpartum depression Case Studies Figure 11. Atypical depression Case Studies Figure 12. Psychotic depression Case Studies Figure 13. Other Case Studies Figure 14. Depression Treatment Therapy Report Years Considered Figure 15. Global Depression Treatment Therapy Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 16. Global Depression Treatment Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 17. Global Depression Treatment Therapy Market Share by Region: 2023 VS 2030 Figure 18. Global Depression Treatment Therapy Market Share by Players in 2023 Figure 19. Global Top Depression Treatment Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Treatment Therapy as of 2023) Figure 20. The Top 10 and 5 Players Market Share by Depression Treatment Therapy Revenue in 2023 Figure 21. North America Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 22. North America Depression Treatment Therapy Market Share by Type (2019-2030) Figure 23. North America Depression Treatment Therapy Market Share by Application (2019-2030) Figure 24. North America Depression Treatment Therapy Market Share by Country (2019-2030) Figure 25. United States Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 26. Canada Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 27. Europe Depression Treatment Therapy Market Size YoY (2019-2030) & (US$ Million) Figure 28. Europe Depression Treatment Therapy Market Share by Type (2019-2030) Figure 29. Europe Depression Treatment Therapy Market Share by Application (2019-2030) Figure 30. Europe Depression Treatment Therapy Market Share by Country (2019-2030) Figure 31. Germany Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. France Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. U.K. Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 34. Italy Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 35. Russia Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 36. Nordic Countries Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 37. China Depression Treatment Therapy Market Size YoY (2019-2030) & (US$ Million) Figure 38. China Depression Treatment Therapy Market Share by Type (2019-2030) Figure 39. China Depression Treatment Therapy Market Share by Application (2019-2030) Figure 40. Asia Depression Treatment Therapy Market Size YoY (2019-2030) & (US$ Million) Figure 41. Asia Depression Treatment Therapy Market Share by Type (2019-2030) Figure 42. Asia Depression Treatment Therapy Market Share by Application (2019-2030) Figure 43. Asia Depression Treatment Therapy Market Share by Region (2019-2030) Figure 44. Japan Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. South Korea Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. China Taiwan Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 47. Southeast Asia Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 48. India Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 49. Australia Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 50. Middle East, Africa, and Latin America Depression Treatment Therapy Market Size YoY (2019-2030) & (US$ Million) Figure 51. Middle East, Africa, and Latin America Depression Treatment Therapy Market Share by Type (2019-2030) Figure 52. Middle East, Africa, and Latin America Depression Treatment Therapy Market Share by Application (2019-2030) Figure 53. Middle East, Africa, and Latin America Depression Treatment Therapy Market Share by Country (2019-2030) Figure 54. Brazil Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. Mexico Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 56. Turkey Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 57. Saudi Arabia Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 58. Israel Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 59. GCC Countries Depression Treatment Therapy Market Size YoY Growth (2019-2030) & (US$ Million) Figure 60. Pfizer Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 61. Teva Pharmaceutical Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 62. Johnson and Johnson Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 63. Merck Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 64. Eli Lily Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 65. Novartis Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 66. Sanofi Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 67. AstraZeneca Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 68. Allergan Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 69. Mayo Clinic Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 71. Takeda Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 72. Brainsway Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 73. Lundbeck Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 74. NeuroStar Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 75. Otsuka Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 76. VistaGen Therapeutics Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 77. Silver Oak Health Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 78. NeuroSigma Revenue Growth Rate in Depression Treatment Therapy Business (2019-2024) Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)